期刊文献+

表达人肝细胞生长因子突变体——NK4工程菌的发酵工艺研究 被引量:1

Fermentation Procedure for Recombinant E.coli Strain Expressing NK4,A Mutant of Human Hepatocyte Growth Factor
下载PDF
导出
摘要 目的 建立重组NK4融合基因工程菌的发酵工艺。方法 采用锥形瓶、发酵罐发酵 ,对工程菌生长和表达条件如pH、诱导时间及诱导剂浓度等方面进行优化。确定其最佳诱导表达条件 ,在 15L自控发酵罐中进行分批补料培养。结果 在 15L发酵罐进行工程菌发酵 ,菌体收获量湿重可达 2 4 .6g L± 0 .98g L ,目的蛋白的表达量保持在菌体总蛋白的 5 0 %左右 ,发酵时间为 11h。结论 建立了周期短、产率高且稳定可靠的发酵工艺。 Objective To develop a fermentation procedure for recombinant E.coli strain expressing NK4 gene.Methods The recombinant E.coli strain was inoculated into Erlenmeyer flasks and incubate d in a fermentor,and the conditions for the growth and expression of the recombi nant strain,such as pH value,time for induction and IPTG concentration,were opti mized.Under the optimal condition,the recombinant strain was incubated in a 15 L automatically-controlled fermentor by fed batch incubation.Results The optimal pH value,time for induction and IPTG concentration were 7 1, 5 h and 1 mmol/L respectively.By the optimal procedure,the bacteria with a wet w eight of 24 6±0 98 g/L were harvested,and the expressed product contained abo ut 50% of total somatic protein.The time duration for fermentation was 11 h. Conclusion A stable and reliable fermentation procedure,with a shor t production cycle and a high yield,was developed. [
出处 《中国生物制品学杂志》 CAS CSCD 2005年第2期132-134,共3页 Chinese Journal of Biologicals
关键词 NK 肝细胞生长因子 表达 融合基因 总蛋白 收获量 左右 发酵罐 发酵工艺 工程菌 Human hepatocyte growth factor Mutant E.coli Fermentation
  • 引文网络
  • 相关文献

参考文献5

  • 1李民,陈常庆,朴勤,陈苏民.利用恒溶氧-补料分批技术高密度培养大肠杆菌生产重组人骨形成蛋白-2A[J].生物工程学报,1998,14(3):270-275. 被引量:35
  • 2Date K,Matsumoto K,Shirmura H, et a1. HGF/NK4 is a specific abtagonist for pleiotroophic actiobs of hepatocyte growth factor. FEBS Lett, 1997,420(1): 1-6.
  • 3Kuba K, Matsumoito K, Ohnishi K,et al. Kringle 1-4 of hepatocyte growthfactor inhibits proliferation and migration of human microvascular endothelial cells. Biochem Biophys Res Gommun,2000,279(3):846-852.
  • 4Davies G,Mason MD, Matin TA,et al. The HGF/SF antigonist NK4 reverse fibroblast and HGF-indused prostate tumor growth and angiogenesis in vivo. Int J Cancer,2003, 106(3) :348-354.
  • 5Jiang WG, Slere E, Hiscox SE, et al. Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in vitro Angiogenesis of HumanVascular Endothelial cells. Clin Cancer Res, 1999,5:3695-3703.

共引文献34

同被引文献13

  • 1刘宏磊,李希,宋后燕,汤其群.人脂联素球状结构域的表达、纯化和功能鉴定[J].复旦学报(医学版),2006,33(1):97-100. 被引量:2
  • 2赵嘉惠,张华屏,王春芳.MTT法在检测细胞增殖方面的探讨[J].山西医科大学学报,2007,38(3):262-263. 被引量:93
  • 3Date K,Matsumoto K,Shimura H,et al.HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor[J].FEBS Lett,1997,420(1):1-6.
  • 4Davies G,Mason MD,Martin TA,et al.The HGF/SF antagonist NK4 reverses fibroblast-and HGF-induced prostate tumor growth and angiogenesis in vivo[J].Int J Cancer,2003,106(3):348-354.
  • 5Kuba K,Matsumoto K,Ohnishi K,et al.Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells[J].Biochem Biophys Res Commun,2000,279(3):846-852.
  • 6Du W,Hattori Y,Yamada T,et al.NK4,an antagonist of hepatocyte growth factor (HGF),inhibits growth of multiple myeloma cells:molecular targeting of angiogenic growth factor[J].Blood,2007,109(7):3 042-3 049.
  • 7Kubota T,Taiyoh H,Matsumura A,et al.NK4,an HGF antagonist,prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells[J].Clin Exp Metastasis,2009,26(5):447-456.
  • 8Nakamura T,Sakai K,Nakamura T,et al.Anti-cancer approach with NK4:bivalent action and mechanisms[J].Anticancer Agents Med Chem,2010,10(1):36-46.
  • 9Thapa A,Shahnawaz M,Karki P,et al.Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins[J].Biotechniques,2008,44(6):787-796.
  • 10Burgess RR.Refolding solubilized inclusion body proteins[J].Methods Enzymol,2009,463:259-282.

引证文献1

二级引证文献1

;
使用帮助 返回顶部